Risk Factors of Frailty in People with Hematologic Malignancies: A Systematic Review and Meta-Analysis
DOI:
https://doi.org/10.60099/prijnr.2026.275617Keywords:
Frailty, Hematologic malignancies, Meta-analysis, Prevalence, Risk factors, Systematic reviewAbstract
Due to the burden of diseases and adverse reactions to treatment, people with hematologic malignancies usually experience frailty. This study determined the risk factors associated with frailty in people with hematologic malignancies. A thorough examination of the literature was conducted across nine databases following the PRISMA guidelines, including PubMed, Web of Science Core Collection, Embase, CINAHL, CNKI, Wanfang Data, CBM, VIP Database, and SinoMed, covering the period from 2001 to July 26, 2024. The Newcastle-Ottawa Scale was used to assess the quality of the included studies, in conjunction with evaluation tools from the Agency for Healthcare Research and Quality. The analysis included 23 studies, encompassing 13,849 participants. A high prevalence of frailty was observed in this study, affecting 27.1% of the participants involved. Several risk factors for frailty were identified, including demographic traits (gender, age), clinical features (hand grip strength, physical activity, comorbidities, advanced disease stages, neurological symptoms), biochemical markers (albumin levels, interleukin-6), and mental state (anaemia, depressive symptoms). Our analysis suggests that frailty is common among people with hematologic malignancies. Nurses should pay attention to individuals who exhibit the above-mentioned influencing factors in clinical practice, prevent the occurrence and progression of frailty, and engage in multidisciplinary collaboration and multi-targeted interventions to better manage individuals with frailty.
References
Fried LP, Tangen CM, Walston J, Newman AB, Hirsch C, Gottdiener J, et al. Frailty in older adults: evidence for a phenotype. J Gerontol A Biol Sci Med Sci. 2001;56(3):M146-56. doi: 10.1093/gerona/56.3.m146.
Munshi L, Dumas G, Rochwerg B, Shoukat F, Detsky M, Fergusson D A, et al. Long-term survival and functional outcomes of critically ill patients with hematologic malignancies: a canadian multicenter prospective study. Intensive Care Med. 2024;50(4):561-572. doi: 10.1007/s00134-024-07349-z.
Francesco M, Stefano L, Alessandra T, Annalisa A, Luigi R, Eliza H, et al. Simplified geriatric assessment in older patients with diffuse large B-cell lymphoma: The Prospective Elderly Project of the Fondazione Italiana Infomi. J Clin Oncol. 2021;39(11):1214-1222. doi: 10.1200/JCO.20.02465.
Sakurai M, Karigane D, Kasahara H, Tomohiko T, Akaru I, Hiroshi M, et al. Geriatric screening tools predict survival outcomes in older patients with diffuse large B cell lymphoma. Ann Hematol. 2019;98(3):669-678. doi: 10.1007/s00277-018-3551-y.
Handforth C, Clegg A, Young C, Simpkins S, Seymour M T, Selby P J, et al. The prevalence and outcomes of frailty in older cancer patients: a systematic review. Ann Oncol. 2015;26(6):1091-1101. doi: 10.1093/annonc/mdu540.
He L, He R, Huang J, Zou C, Fan Y. Impact of frailty on all-cause mortality and major bleeding in patients with atrial fibrillation: a meta-analysis. Ageing Res Rev. 2022;73:101527. doi: 10.1016/j.arr.2021.101527.
Pilotto A, Custodero C, Maggi S, Polidori M C, Veronese N, Ferrucci L. A multidimensional approach to frailty in older people. Ageing Res Rev. 2020;60:101047. doi: 10.1016/j.arr.2020.101047. Epub 2020 Mar 21.
Atakul E, Akyar İ. Frailty prevalence and characteristics in older adults with hematologic cancer: a descriptive study. Asia Pac J Oncol Nurs. 2019;6(1):43-49. doi: 10.4103/apjon.apjon_35_18.
Arora M, Sun C L, Ness K K, Teh J B, Wu J, Francisco L, et al. Physiologic frailty in nonelderly hematopoietic cell transplantation patients: results from the Bone Marrow Transplant Survivor Study. JAMA Oncol. 2016;2(10):1277-1286. doi: 10.1001/jamaoncol.2016.0855.
Zeng X, Zhang Y, Kwong J S, Zhang C, Li S, Sun F, et al. The methodological quality assessment tools for preclinical and clinical studies, systematic review and meta-analysis, and clinical practice guideline: a systematic review. J Evid Based Med. 2015;8(1):2-10. doi: 10.1111/jebm.12141.
Stang A. Critical evaluation of the Newcastle Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses. Eur J Epidemiol. 2010;25(9):603-605. doi: 10.1007/s10654-010-9491-z.
Smeland K B, Loge J H, Aass H, Aspelin T, Bersvendsen H, Bolstad N, et al. Chronic fatigue is highly prevalent in survivors of autologous stem cell transplantation and associated with IL-6, neuroticism, cardiorespiratory fitness, and obesity. Bone Marrow Transplant. 2019;54(4):607-610. doi: 10.1038/s41409-018-0342-y.
Eissa H M, Lu L, Baassiri M, Bhakta N, Ehrhardt M J, Triplett B M, et al. Chronic disease burden and frailty in survivors of childhood HSCT: a report from the St. Jude Lifetime Cohort Study. Blood Adv. 2017;1(24):2243-2246. doi: 10.1182/bloodadvances.2017010280.
Higgins J P, Thompson S G. Quantifying heterogeneity in a meta-analysis. Stat Med. 2002;21(11):1539-1558. doi: 10.1002/sim.1186.
Park S, Hong J, Hwang I, Ahn J Y, Cho E Y, Park J, et al. Comprehensive geriatric assessment in elderly patients with newly diagnosed aggressive non-Hodgkin lymphoma treated with multiagent chemotherapy. J Geriatr Oncol. 2015;6(6):470-478. doi: 10.1016/j.jgo.2015.10.183.
Verwaaijen E J, van Hulst A M, Hartman A, Pieters R, Fiocco M, Pluijm SMF, et al. Physical frailty deteriorates after a 5-day dexamethasone course in children with acute lymphoblastic leukemia, results of a national prospective study. Cancer Med. 2023;12(24):22304-22315. doi: 10.1002/cam4.6779.
Wilson C L, Chemaitilly W, Jones K E, Kaste S C, Srivastava D K, Ojha R P, et al. Modifiable factors associated with aging phenotypes among adult survivors of childhood acute lymphoblastic leukemia. J Clin Oncol. 2016;34(21):2509-2515. doi: 10.1200/JCO.2015.64.9525.
Luo S, Zhao H, Gan X, He Y, Wu C, Ying Y. Nomogram model for predicting frailty of people with hematologic malignancies - a cross-sectional survey. Asia Pac J Oncol Nurs. 2023;10(11):100307. doi: 10.1016/j.apjon.2023.100307.
Avila J, DuMontier C, Cernik C, Uno H, Hshieh T, Ho K, et al. Marital status, frailty, and survival in older adults with blood cancer. J Geriatr Oncol. 2023;14(8):101589. doi: 10.1016/j.jgo.2023.101589.
Rach A M, Crabtree V M, Brinkman T M, Zeltzer L, Marchak J G, Srivastava D, et al. Predictors of fatigue and poor sleep in adult survivors of childhood Hodgkin's lymphoma: a report from the childhood cancer survivor study. J Cancer Surviv. 2017;11(2):256-263. doi: 10.1007/s11764-016-0583-y.
Singh S, Cao Q, Demorest C, He F, Kramer A, Holtan S, et al. The prevalence of pretransplant frailty and mental distress in hematopoietic cell transplantation and association with clinical outcomes. Transplant Cell Ther. 2024;30(9):919. doi: 10.1016/j.jtct.2024.05.026.
Suominen A, Haavisto A, Mathiesen S, Mejdahl Nielsen M, Lähteenmäki P M, Sørensen K, et al. Physical fitness and frailty in males after allogeneic hematopoietic stem cell transplantation in childhood: a long-term follow-up study. Cancers (Basel). 2022;14(14):3310. doi: 10.3390/cancers14143310.
Hamre H, Zeller B, Kanellopoulos A, Ruud E, Fosså S D, Loge J H, et al. Serum cytokines and chronic fatigue in adults surviving after childhood leukemia and lymphoma. Brain Behav Immun. 2013;30(May):80-87. doi: 10.1016/j.bbi.2013.01.006.
Jiejing W, Ting L, Yanping Y, Biaojin H, Yi X. Construction and evaluation of a risk assessment model for debilitating syndrome in patients with malignant tumors. China Medical Guide. 2023;20(24):59-63. doi: 10.20047/j.issn1673-7210.2023.24.14 (in China).
Lee H S, Lee J, Jo J C, Jung S H, Lee J J, Kim D, et al. Development of a new clinical index to easily assess frailty of elderly patients with multiple myeloma in Asian population. Sci Rep. 2021;11(1):22907. doi: 10.1038/s41598-021-02433-6.
Nora B, Richman J S, Landier W, Shrestha S, Bruxvoort K J, Hageman L, et al. Prefrailty after blood or marrow transplantation and the risk of subsequent mortality. Leukemia. 2024;38(7):1592-1599. doi: 10.1038/s41375-024-02238-2.
Velghe A, De Buyser S, Noens L, Demuync, R, Petrovic M. Hand grip strength as a screening tool for frailty in older patients with haematological malignancies. Acta Clin Belg. 2016;71(4):227-230. doi: 10.1080/17843286.2016.1162381.
Busson R, van der Kaaij M, Mounier N, Aleman BMP, Thiéblemont C, Stamatoullas A, et al. Fatigue level changes with time in long-term Hodgkin and non-Hodgkin lymphoma survivors: a joint eortc-lysa cross-sectional study. Health Qual Life Outcomes. 2019;17(1):115. doi: 10.1186/s12955-019-1186-x.
Daniëls L A, Oerlemans S, Krol A D, Creutzberg C L, van de Poll-Franse L V. Chronic fatigue in hodgkin lymphoma survivors and associations with anxiety, depression and comorbidity. Br J Cancer. 2014,110(4):868-874. doi: 10.1038/bjc.2013.779.
Majhail N S, Ness K K, Burns L J, Sun C L, Carter A, Francisco L, et al. Late effects in survivors of Hodgkin and non-Hodgkin lymphoma treated with autologous hematopoietic cell transplantation: a report from the bone marrow transplant survivor study. Biol Blood Marrow Transplant. 2007;13(10):1153-1159. doi: 10.1016/j.bbmt.2007.06.003.
Alexander F, Smeland K H, Fluge Ø, Tronstad K J,Loge J H, Midttun Ø, et al. Metabolic analysis of amino acids and vitamin B6 pathways in lymphoma survivors with cancer related chronic fatigue. PLoS One. 2020;15(1):e227384. doi: 10.1371/journal.pone.0227384.
Steur L, Kaspers G, van Someren E, van Eijkelenburg NKA, van der Sluis I M, Dors N, et al. The impact of maintenance therapy on sleep-wake rhythms and cancer-related fatigue in pediatric acute lymphoblastic leukemia. Support Care Cancer. 2020;28(12):5983-5993. doi: 10.1007/s00520-020-05444-7.
Jing B, Wenmin S, Lili S, Tongwei N. Analysis of frailty and influencing factors in elderly patients with multiple myeloma. Shanghai Nursing. 2021;21(03):36-39 (in China).
Yinning G, Xueyi L, Xiaoman J, Ting X, Qin X. Meta-analysis of factors influencing frailty in tumor patients. Chinese general medicine. 2023;26(8):989-996 (in China).
Fritzenschaft L, Boehm F, Rothenbacher D, Denkinger M, Dallmeier D. Association of blood biomarkers with frailty - a mapping review. Ageing Res Rev. 2025;109:102761. doi: 10.1016/j.arr.2025.102761.
Zhou Y, Yuan Y, Wang X, Qi K, Zhang S, Zhang Y, et al. Sedentary behavior and physical frailty among rural older adults in China: the moderating effect of social isolation. J Am Med Dir Assoc. 2024;25(3):500-505. doi: 10.1016/j.jamda.2023.08.020.
Kiss N, Abbott G, Daly R M, Denehy L, Edbrooke L, Baguley B J, et al. Multimorbidity and the risk of malnutrition, frailty and sarcopenia in adults with cancer in the UK Biobank. J Cachexia Sarcopenia Muscle. 2024;15(5):1696-1707. doi: 10.1002/jcsm.13523.
Cesari M. How polypharmacy affects frailty. Expert Rev Clin Pharmacol. 2020;13(11):1179-1181. doi: 10.1080/17512433.2020.1829467.
Clauw D J. From fibrositis to fibromyalgia to nociplastic pain: how rheumatology helped get us here and where do we go from here?. Ann Rheum Dis. 2024;83(11):1421-1427. doi: 10.1136/ard-2023-225327.
Georgiou P, Farmer C A, Medeiros G C, Yuan P, Johnston J, Kadriu B, et al. Associations between hypothalamic-pituitary-adrenal (HPA) axis hormone levels, major depression features and antidepressant effects of ketamine. J Affect Disord. 2025;373:126-132. doi: 10.1016/j.jad.2024.12.036.
Downloads
Published
How to Cite
Issue
Section
Categories
License
Copyright (c) 2025 Pacific Rim International Journal of Nursing Research
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
Copyright: The Pacific Rim International Journal of Nursing Research, Thailand Nursing & Midwifery Council has exclusive rights to publish, reproduce and distribute the manuscript and all contents therein.
.png)
